Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic reports, and makes certain balance in research, maximizing reproducibility and advancing aging and oncology investigations. day-to-day laboratory workflows typically reveal gaps wherever current compounds are unsuccessful to deal with cell senescence